Kanabo and Medocann to develop unique cannabis strains for UK and Germany
The deal will see the companies develop new products to target specific medical conditions.Â
The deal will see the companies develop new products to target specific medical conditions.Â
The medicine will now be available on prescription for patients in the UK.
Guernsey says that the majority of the applications received so far aim to produce cannabis-based medicinal products.
American Green has entered into a new, five-year management services agreement with Curaleaf Holdings.
Lidl has recalled hemp products sold in its Irish stores and warned customers over high THC levels.
The firm has secured a $24 million deal for the supply of its cannabis-based products to the US.
The move will see Flora’s finished cannabis products reach patients in Europe.Â
The products are set to be made available to patients in the coming weeks
Khiron has expanded its product offerings in both the UK and Germany.
This is the first acquisition made since Yooma completed its dual-listing on the AQSE Growth Market in London.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.